Il­lu­mi­na board agrees to spin off Grail rather than sell the can­cer di­ag­nos­tics firm

Il­lu­mi­na’s board has de­cid­ed to spin out Grail in­to its own com­pa­ny this month, the DNA se­quenc­ing com­pa­ny an­nounced Mon­day. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.